137 related articles for article (PubMed ID: 2524313)
1. [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
Coen G; Nazzaro L; Cipriani P; Giordano A; Mazzaferro S; Petta S; Reale MG; Smacchi A
Clin Ter; 1989 Feb; 128(4):243-9. PubMed ID: 2524313
[TBL] [Abstract][Full Text] [Related]
2. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
Fraschini F; Scaglione F; Alessandria M; Gattei G
Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
[TBL] [Abstract][Full Text] [Related]
3. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
4. [Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
Yoshida K; Uchijima Y; Kobayashi N; Suwata J; Nakame Y; Saitoh H; Negishi T; Yamada T; Kageyama Y; Kura N
Hinyokika Kiyo; 1988 Dec; 34(12):2225-32. PubMed ID: 3071130
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of aztreonam for serious gram-negative bacterial infections.
Raz R; Flatau E; Sudarsky M; Keness J
Chemioterapia; 1988 Feb; 7(1):42-5. PubMed ID: 3378275
[TBL] [Abstract][Full Text] [Related]
6. Role of aztreonam in urinary tract infections.
Roberts JA
Urology; 1988 Jun; 31(6 Suppl):39-44. PubMed ID: 3287749
[TBL] [Abstract][Full Text] [Related]
7. UTIs and two new antibiotics in the elderly.
Jones SR; Kimbrough R
Geriatrics; 1988 Jul; 43(7):49-52, 55-8. PubMed ID: 3290058
[TBL] [Abstract][Full Text] [Related]
8. Aztreonam versus cefamandole in the treatment of urinary tract infections.
Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
[TBL] [Abstract][Full Text] [Related]
9. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
[No Abstract] [Full Text] [Related]
10. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
Malcangi A; Pesce S; Vitale M; Martinetto P
G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of aztreonam for complicated urinary tract infection].
Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
[TBL] [Abstract][Full Text] [Related]
13. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the therapeutic efficacy of aztreonam in the treatment of infection caused by sensitive microorganisms].
Tirone F; Musca G; Filomia D; Vigna L
Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):85-8. PubMed ID: 2798996
[TBL] [Abstract][Full Text] [Related]
16. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of aztreonam (AZT) in the treatment of complicated urinary tract infections].
Mizutani S; Iwao N; Miyoshi S; Kameoka H; Yano H; Kishimoto T; Sakurai T; Wakatsuki A; Nakamura T; Honda M
Hinyokika Kiyo; 1989 Dec; 35(12):2155-61. PubMed ID: 2694836
[TBL] [Abstract][Full Text] [Related]
18. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of azthreonam in severe urinary tract infections].
Guibert J; Acar JF; Miegi M
Pathol Biol (Paris); 1984 May; 32(5):446-9. PubMed ID: 6377208
[TBL] [Abstract][Full Text] [Related]
20. [Clinical reevaluation of aztreonam (AZT) on urinary tract infections].
Kohri K; Kurita T; Sakaguti H; Kadowaki T; Iguti M; Kanda H; Nagi N; Kataoka K; Kawamura M; Mitsubayashi S
Hinyokika Kiyo; 1989 Apr; 35(4):711-6. PubMed ID: 2660527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
